한글목차

혈장요법 세계 시장 규모는 2030년까지 7억 8,250만 달러에 달할 것으로 전망

2023년 4억 7,630만 달러로 추정되는 혈장요법 세계 시장은 2030년에는 7억 8,250만 달러에 달할 것으로 예상되며, 분석 기간인 2023-2030년간 7.3%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다. 본 보고서에서 분석한 부문 중 하나인 순수 PRP는 9.0%의 연평균 복합 성장률(CAGR)을 기록하여 분석 기간 종료 시점에 4억 6,840만 달러에 이를 것으로 예상됩니다. 백혈구가 풍부한 PRP 부문의 성장률은 분석 기간 동안 CAGR 4.8%로 추정됩니다.

미국 시장은 1억 2,920만 달러로 추정, 중국은 CAGR 6.7%로 성장할 것으로 예상

미국의 혈장 치료 시장은 2023년 1억 2,920만 달러로 추정됩니다. 세계 2위의 경제 대국인 중국은 2023년부터 2030년까지 연평균 6.7%의 성장률을 보이며 2030년에는 1억 1,980만 달러 규모에 도달할 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 6.7%와 5.9%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다. 유럽에서는 독일이 연평균 5.5%의 성장률을 보일 것으로 예상됩니다.

세계 혈장요법 시장 - 주요 동향 및 촉진요인 요약

내면으로부터의 치유: 혈장요법의 약속과 과정

혈소판이 풍부한 혈장(PRP) 요법으로도 알려진 혈장 요법은 환자 자신의 혈액을 이용해 신체 여러 부위의 치유를 촉진하는 치료법입니다. 혈소판과 성장인자가 풍부한 혈장을 원심분리하여 혈소판과 성장인자가 풍부한 혈장을 분리하는 과정으로 시작됩니다. 이 농축된 혈장을 손상된 부위에 주입합니다. 혈소판은 혈액 응고와 조직 복구에 중요한 역할을 하며, 혈소판이 방출하는 성장 인자는 세포 증식, 조직 재생 및 치유를 촉진합니다. 이 치료법은 회복을 촉진하고 염증을 억제할 수 있기 때문에 정형외과, 스포츠 의학, 피부과 등의 분야에서 인기가 높아지고 있습니다.

혈장요법는 다양한 의료 분야에서 어떻게 적용되고 있나요?

혈장요법는 그 재생 특성으로 인해 다양한 의료 분야에서 활용되고 있습니다. 정형외과 및 스포츠 의학에서 PRP 주사는 테니스 엘보나 아킬레스 건염과 같은 만성적인 힘줄 손상과 인대 염좌 및 근육 긴장과 같은 급성 손상을 치료하는 데 사용됩니다. 이 주사는 또한 수술 후 회복을 돕고 치유 과정을 강화하며 다운 타임을 줄일 수 있습니다. 피부과에서 PRP는 얼굴 회춘, 주름 감소, 일반적으로 '뱀파이어 페이셜'로 알려진 시술로 피부 질감을 개선하는 데 사용됩니다. 혈장요법의 다재다능함은 환자에게 자연스럽고 효과적인 치료 옵션을 제공함으로써 수복 및 미용 의료 모두에서 귀중한 도구가 될 수 있습니다.

혈장요법의 연구 및 응용 동향은?

혈장 치료 분야는 지속적인 연구와 임상적 발전으로 끊임없이 진화하고 있습니다. 중요한 추세 중 하나는 치료 효과를 높이기 위해 줄기세포 치료나 미세침과 같은 다른 치료와 함께 PRP를 사용하는 경우가 증가하고 있다는 점입니다. 연구자들은 또한 골관절염과 같은 퇴행성 관절 질환의 치료, 당뇨병 환자의 상처 치유 촉진과 같은 새로운 분야에서 혈장요법의 효능을 모색하고 있으며, PRP 제조 기술의 발전으로 치료의 일관성과 효능이 개선되어 더욱 신뢰할 수 있고 효과적입니다. 또한, PRP의 특정 성분에 대한 이해와 혈소판 및 성장인자의 농도를 어떻게 조절하여 다양한 병태생리에 최적화할 수 있는지에 대한 이해에 중점을 두고 있습니다. 이러한 추세는 PRP의 적용 범위를 넓히고 환자 결과를 개선하기 위한 혈장 치료 연구의 역동적인 특성을 반영하고 있습니다.

혈장요법 시장의 성장을 가속하는 요인은 무엇인가?

혈장 치료 시장의 성장은 혁신적이고 효과적인 치료에 대한 수요 증가를 반영하는 몇 가지 요인에 의해 주도되고 있으며, PRP 치료의 장점에 대한 인식이 높아지면서 더 많은 환자와 의료 서비스 제공업체가 저침습성과 낮은 부작용 위험과 결합하여 더 많은 환자와 의료 서비스 제공업체를 끌어들이고 있습니다. PRP의 제조 및 전달 방법의 기술 발전은 치료의 효과와 신뢰성을 향상시켜 그 인기를 더욱 높이고 있습니다. 정형외과, 피부과, 모발 재생 등 다양한 의료 분야에서 혈장요법의 적용이 확대되면서 시장 성장에 기여하고 있습니다. 또한, 재생의료와 개인맞춤형 치료 증가로 인해 자연스럽고 환자 맞춤형 치료법으로 PRP에 대한 관심이 높아지고 있습니다. 신흥국 시장의 의료비 지출 증가와 의료 인프라 확충도 시장 성장을 뒷받침하고 있으며, 이러한 첨단 치료법을 보다 쉽게 접할 수 있도록 돕고 있습니다. 이러한 요인들이 종합적으로 작용하여 혈장요법 시장의 견조한 성장을 보장하고, 현대 의료 분야에서 혈장요법의 큰 잠재력을 강조하고 있습니다.

조사 대상 기업 예시(총 38건)

• Active Sports Medicine
• Alkahest, Inc.
• Bio Products Laboratory Ltd.
• Biolife Plasma Services
• CSL Ltd.
• Excelsior Orthopaedics
• Glofinn Oy
• Juventix
• Octapharma AG
• Origin, Inc.

목차

제1장 조사 방법

제2장 주요 요약

• 시장 개요
• 주요 기업
• 시장 동향과 촉진요인
• 세계 시장 전망

제3장 시장 분석

• 미국
• 캐나다
• 일본
• 중국
• 유럽
• 프랑스
• 독일
• 이탈리아
• 영국
• 기타 유럽
• 아시아태평양
• 기타 지역

제4장 경쟁

영문목차

Global Plasma Therapy Market to Reach US$782.5 Million by 2030

The global market for Plasma Therapy estimated at US$476.3 Million in the year 2023, is expected to reach US$782.5 Million by 2030, growing at a CAGR of 7.3% over the analysis period 2023-2030. Pure PRP, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$468.4 Million by the end of the analysis period. Growth in the Leukocyte-Rich PRP segment is estimated at 4.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$129.2 Million While China is Forecast to Grow at 6.7% CAGR

The Plasma Therapy market in the U.S. is estimated at US$129.2 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$119.8 Million by the year 2030 trailing a CAGR of 6.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.7% and 5.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.5% CAGR.

Global Plasma Therapy Market - Key Trends and Drivers Summarized

Healing from Within: The Promises and Processes of Plasma Therapy

Plasma therapy, also known as platelet-rich plasma (PRP) therapy, is a medical treatment that utilizes the patient’s own blood to accelerate healing in various parts of the body. The process begins with a blood draw, from which the plasma, rich in platelets and growth factors, is isolated through centrifugation. This concentrated plasma is then injected into the injured or affected area. Platelets play a crucial role in clotting and tissue repair, and the growth factors they release can stimulate cell proliferation, tissue regeneration, and healing. This therapy is increasingly popular in fields like orthopedics, sports medicine, and dermatology for its potential to enhance recovery and reduce inflammation.

How Is Plasma Therapy Applied in Different Medical Fields?

Plasma therapy is utilized across a range of medical fields due to its regenerative properties. In orthopedics and sports medicine, PRP injections are used to treat chronic tendon injuries, such as tennis elbow and Achilles tendinitis, as well as acute injuries like ligament sprains and muscle strains. These injections can also aid in the recovery from surgeries, enhancing the healing process and reducing downtime. In dermatology, plasma therapy is employed for facial rejuvenation, reducing wrinkles, and improving skin texture through procedures commonly known as the “vampire facial.” Additionally, PRP is used in hair restoration treatments, promoting hair growth in patients experiencing hair loss. The versatility of plasma therapy makes it a valuable tool in both restorative and aesthetic medicine, offering patients a natural and effective treatment option.

What Are the Current Trends in Plasma Therapy Research and Applications?

The field of plasma therapy is continuously evolving, driven by ongoing research and clinical advancements. One significant trend is the increasing use of PRP in combination with other treatments, such as stem cell therapy and microneedling, to enhance therapeutic outcomes. Researchers are also exploring the efficacy of plasma therapy in new areas, such as treating degenerative joint diseases like osteoarthritis and promoting wound healing in diabetic patients. Advances in PRP preparation techniques are improving the consistency and potency of the treatments, making them more reliable and effective. Additionally, there is a growing emphasis on understanding the specific components of PRP and how different concentrations of platelets and growth factors can be optimized for various conditions. These trends reflect the dynamic nature of plasma therapy research, aiming to broaden its applications and improve patient outcomes.

What Factors Are Driving the Growth in the Plasma Therapy Market?

The growth in the plasma therapy market is driven by several factors, reflecting the increasing demand for innovative and effective medical treatments. Rising awareness of the benefits of PRP therapy, coupled with its minimally invasive nature and lower risk of side effects, is attracting more patients and healthcare providers. Technological advancements in PRP preparation and delivery methods are enhancing the efficacy and reliability of treatments, further boosting their popularity. The expanding applications of plasma therapy in diverse medical fields, including orthopedics, dermatology, and hair restoration, are contributing to market growth. Additionally, the growing trend towards regenerative medicine and personalized treatments is driving interest in PRP as a natural and patient-specific therapy. Increased healthcare spending and the expansion of medical infrastructure in developing regions are also supporting market growth, making these advanced treatments more accessible. These factors collectively ensure robust growth in the plasma therapy market, highlighting its significant potential in modern healthcare.

Select Competitors (Total 38 Featured) -

• Active Sports Medicine
• Alkahest, Inc.
• Bio Products Laboratory Ltd.
• Biolife Plasma Services
• CSL Ltd.
• Excelsior Orthopaedics
• Glofinn Oy
• Juventix
• Octapharma AG
• Origin, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Plasma Therapy - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • Global Economic Update
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Plasma Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Plasma Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 3: World 16-Year Perspective for Plasma Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Pure PRP by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Pure PRP by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 6: World 16-Year Perspective for Pure PRP by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Leukocyte-Rich PRP by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Leukocyte-Rich PRP by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 9: World 16-Year Perspective for Leukocyte-Rich PRP by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Pure Platelet-Rich Fibrin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Pure Platelet-Rich Fibrin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 12: World 16-Year Perspective for Pure Platelet-Rich Fibrin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 13: World Recent Past, Current & Future Analysis for Leukocyte-Rich Fibrin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 14: World Historic Review for Leukocyte-Rich Fibrin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 15: World 16-Year Perspective for Leukocyte-Rich Fibrin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 16: World Plasma Therapy Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Orthopedics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Orthopedics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 19: World 16-Year Perspective for Orthopedics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Dermatology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Dermatology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 22: World 16-Year Perspective for Dermatology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Dentistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Dentistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 25: World 16-Year Perspective for Dentistry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 28: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Plasma Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 29: USA Recent Past, Current & Future Analysis for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 30: USA Historic Review for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 31: USA 16-Year Perspective for Plasma Therapy by Type - Percentage Breakdown of Value Sales for Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin for the Years 2014, 2024 & 2030
  • TABLE 32: USA Recent Past, Current & Future Analysis for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 34: USA 16-Year Perspective for Plasma Therapy by Application - Percentage Breakdown of Value Sales for Orthopedics, Dermatology, Dentistry and Other Applications for the Years 2014, 2024 & 2030
• CANADA
  • TABLE 35: Canada Recent Past, Current & Future Analysis for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 36: Canada Historic Review for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 37: Canada 16-Year Perspective for Plasma Therapy by Type - Percentage Breakdown of Value Sales for Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin for the Years 2014, 2024 & 2030
  • TABLE 38: Canada Recent Past, Current & Future Analysis for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 39: Canada Historic Review for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 40: Canada 16-Year Perspective for Plasma Therapy by Application - Percentage Breakdown of Value Sales for Orthopedics, Dermatology, Dentistry and Other Applications for the Years 2014, 2024 & 2030
• JAPAN
  • Plasma Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 41: Japan Recent Past, Current & Future Analysis for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 42: Japan Historic Review for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 43: Japan 16-Year Perspective for Plasma Therapy by Type - Percentage Breakdown of Value Sales for Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin for the Years 2014, 2024 & 2030
  • TABLE 44: Japan Recent Past, Current & Future Analysis for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 45: Japan Historic Review for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 46: Japan 16-Year Perspective for Plasma Therapy by Application - Percentage Breakdown of Value Sales for Orthopedics, Dermatology, Dentistry and Other Applications for the Years 2014, 2024 & 2030
• CHINA
  • Plasma Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 47: China Recent Past, Current & Future Analysis for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 48: China Historic Review for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 49: China 16-Year Perspective for Plasma Therapy by Type - Percentage Breakdown of Value Sales for Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin for the Years 2014, 2024 & 2030
  • TABLE 50: China Recent Past, Current & Future Analysis for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 51: China Historic Review for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 52: China 16-Year Perspective for Plasma Therapy by Application - Percentage Breakdown of Value Sales for Orthopedics, Dermatology, Dentistry and Other Applications for the Years 2014, 2024 & 2030
• EUROPE
  • Plasma Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 53: Europe Recent Past, Current & Future Analysis for Plasma Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 54: Europe Historic Review for Plasma Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 55: Europe 16-Year Perspective for Plasma Therapy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • TABLE 56: Europe Recent Past, Current & Future Analysis for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 57: Europe Historic Review for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 58: Europe 16-Year Perspective for Plasma Therapy by Type - Percentage Breakdown of Value Sales for Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin for the Years 2014, 2024 & 2030
  • TABLE 59: Europe Recent Past, Current & Future Analysis for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 60: Europe Historic Review for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 61: Europe 16-Year Perspective for Plasma Therapy by Application - Percentage Breakdown of Value Sales for Orthopedics, Dermatology, Dentistry and Other Applications for the Years 2014, 2024 & 2030
• FRANCE
  • Plasma Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 62: France Recent Past, Current & Future Analysis for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 63: France Historic Review for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 64: France 16-Year Perspective for Plasma Therapy by Type - Percentage Breakdown of Value Sales for Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin for the Years 2014, 2024 & 2030
  • TABLE 65: France Recent Past, Current & Future Analysis for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 66: France Historic Review for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 67: France 16-Year Perspective for Plasma Therapy by Application - Percentage Breakdown of Value Sales for Orthopedics, Dermatology, Dentistry and Other Applications for the Years 2014, 2024 & 2030
• GERMANY
  • Plasma Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 68: Germany Recent Past, Current & Future Analysis for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 69: Germany Historic Review for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 70: Germany 16-Year Perspective for Plasma Therapy by Type - Percentage Breakdown of Value Sales for Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin for the Years 2014, 2024 & 2030
  • TABLE 71: Germany Recent Past, Current & Future Analysis for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 72: Germany Historic Review for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 73: Germany 16-Year Perspective for Plasma Therapy by Application - Percentage Breakdown of Value Sales for Orthopedics, Dermatology, Dentistry and Other Applications for the Years 2014, 2024 & 2030
• ITALY
  • TABLE 74: Italy Recent Past, Current & Future Analysis for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 75: Italy Historic Review for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 76: Italy 16-Year Perspective for Plasma Therapy by Type - Percentage Breakdown of Value Sales for Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin for the Years 2014, 2024 & 2030
  • TABLE 77: Italy Recent Past, Current & Future Analysis for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 78: Italy Historic Review for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 79: Italy 16-Year Perspective for Plasma Therapy by Application - Percentage Breakdown of Value Sales for Orthopedics, Dermatology, Dentistry and Other Applications for the Years 2014, 2024 & 2030
• UNITED KINGDOM
  • Plasma Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 80: UK Recent Past, Current & Future Analysis for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 81: UK Historic Review for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 82: UK 16-Year Perspective for Plasma Therapy by Type - Percentage Breakdown of Value Sales for Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin for the Years 2014, 2024 & 2030
  • TABLE 83: UK Recent Past, Current & Future Analysis for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 84: UK Historic Review for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 85: UK 16-Year Perspective for Plasma Therapy by Application - Percentage Breakdown of Value Sales for Orthopedics, Dermatology, Dentistry and Other Applications for the Years 2014, 2024 & 2030
• REST OF EUROPE
  • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 87: Rest of Europe Historic Review for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 88: Rest of Europe 16-Year Perspective for Plasma Therapy by Type - Percentage Breakdown of Value Sales for Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin for the Years 2014, 2024 & 2030
  • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 90: Rest of Europe Historic Review for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 91: Rest of Europe 16-Year Perspective for Plasma Therapy by Application - Percentage Breakdown of Value Sales for Orthopedics, Dermatology, Dentistry and Other Applications for the Years 2014, 2024 & 2030
• ASIA-PACIFIC
  • Plasma Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 93: Asia-Pacific Historic Review for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 94: Asia-Pacific 16-Year Perspective for Plasma Therapy by Type - Percentage Breakdown of Value Sales for Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin for the Years 2014, 2024 & 2030
  • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 96: Asia-Pacific Historic Review for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 97: Asia-Pacific 16-Year Perspective for Plasma Therapy by Application - Percentage Breakdown of Value Sales for Orthopedics, Dermatology, Dentistry and Other Applications for the Years 2014, 2024 & 2030
• REST OF WORLD
  • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 99: Rest of World Historic Review for Plasma Therapy by Type - Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 100: Rest of World 16-Year Perspective for Plasma Therapy by Type - Percentage Breakdown of Value Sales for Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin for the Years 2014, 2024 & 2030
  • TABLE 101: Rest of World Recent Past, Current & Future Analysis for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 102: Rest of World Historic Review for Plasma Therapy by Application - Orthopedics, Dermatology, Dentistry and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 103: Rest of World 16-Year Perspective for Plasma Therapy by Application - Percentage Breakdown of Value Sales for Orthopedics, Dermatology, Dentistry and Other Applications for the Years 2014, 2024 & 2030

IV. COMPETITION